Last updated on July 2017

A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.


Brief description of study

A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.

Detailed Study Description

The purpose of this study is to evaluate the efficacy of ADX Ophthalmic Solution on anterior chamber cell count and evaluate the signs and symptoms of ADX-102 Ophthalmic Solution on anterior chamber flare in subjects with non-infectious anterior uveitis.

Clinical Study Identifier: TX151271

Contact Investigators or Research Sites near you

Start Over

Angela Smit, CCRP

Clinical Eye Research Center of Connecticut
Danbury, CT USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.